NCT02663999View on ClinicalTrials.gov

A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2016

Conditions

Healthy

Interventions

DRUG

diazepam nasal spray

diazepam nasal spray at two dose levels (DL). One dose of diazepam nasal spray is administered as two intranasal sprays; one in each nostril using a nasal spray device.

Trial Locations (1)

75247

Site #001, Dallas